Legal Brawl Over Patent Rules Creates Wide Trenches As More Groups Weigh In
Executive Summary
The legal battle over the U.S. Patent and Trademark Office's efforts to limit certain patent filings intensified last month as various parties jumped into the fray
You may also be interested in...
PTO Hit With Second Lawsuit Opposing Continuation Rules As GSK Joins Fray
GlaxoSmithKline has filed suit against the Patent and Trademark Office to block new rules limiting the number of continuation applications a patent holder can file
New Patent Rules May Hurt Biotech Industry; Limits Set On Certain Filings
The U.S. Patent and Trademark Office is implementing new rules on patent filings that will make it tougher for biotechnology companies to protect their inventions
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.